Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
Clinical trial NCT01048320 · COMPLETED
Trial details
- NCT number
- NCT01048320
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.